Skip to main content
Top

08-17-2018 | Medications | Review | Article

Patients’ Perspectives of Oral and Injectable Type 2 Diabetes Medicines, Their Body Weight and Medicine-Taking Behavior in the UK: A Systematic Review and Meta-Ethnography

Journal: Diabetes Therapy

Authors: Aikaterini Psarou, Helen Cooper, John P. H. Wilding

Publisher: Springer Healthcare

Abstract

The aim of this review is to identify peoples’ perspectives of their glucose-lowering and anti-obesity drugs in relation to diabetes and weight control and to explore how these views affect medication adherence. Theoretical perspectives associated with medicine-taking behavior are also explored. The systematic review was based on a meta-ethnography of qualitative studies identified through a search of 12 medical and social science databases and subsequent citation searches. The quality of all studies was assessed. Sixteen studies were included with data from 360 UK individuals. No relevant studies were identified which focused on anti-obesity and non-insulin injectable drugs. The review revealed that the patients’ perspectives and emotional state were influenced by starting and/or changing to a new glucose-lowering medicine. These were also influenced by prior medication experience, disease perceptions and interactions with clinicians. Despite reports of positive experiences with and positive perceptions of medicines, and of participation in strategies to regain life control, medication non-adherence was common. Accepting glucose-lowering medicines impacted on the individual’s perception of lifestyle changes, and it was notable that weight loss was not perceived as a strategy to support diabetes management. Synthesis revealed that more than one theory is required to explain medicine-taking behavior. New insights into the underlying factors of poor adherence and the specific practical issues identified in this review can help in the development of patient-centered interventions.
Funding: Diabetes UK.
Literature
1.
Diabetes UK. Type 2 diabetes and obesity: a heavy burden. London: Diabetes UK; 2005.
2.
Philippe J, Raccah D. Treating type 2 diabetes: how safe are current therapeutic agents? Int J Clin Pract. 2009;63(2):321–32.CrossRefPubMed
3.
Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–24. https://​doi.​org/​10.​2337/​diacare.​27.​5.​1218.CrossRefPubMed
4.
Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32(6):725–37.CrossRefPubMed
5.
Rucker D, Padwal R, Li SK, Curioni C, Lau DC. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ. 2007;335(7631):1194–9.CrossRefPubMedPubMedCentral
6.
Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2):CD000011. https://​doi.​org/​10.​1002/​14651858.​CD000011.​pub3.
7.
Vermeire EI, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;(2):CD003638. https://​doi.​org/​10.​1002/​14651858.​CD003638.​pub2.
8.
Sapkota S, Brien JA, Greenfield J, Aslani P. A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes—impact on adherence. PLoS One. 2015;10(2):e0118296.CrossRefPubMedPubMedCentral
9.
Steiner JF, Earnest MA. The language of medication-taking. Ann Intern Med. 2000;132(11):926–30.CrossRefPubMed
10.
Hearnshaw H, Lindenmeyer A. What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements. Diabet Med. 2006;23(7):720–8.CrossRefPubMed
11.
Blackburn DF, Swidrovich J, Lemstra M. Non-adherence in type 2 diabetes: practical considerations for interpreting the literature. Patient Prefer Adherence. 2013;7:183.CrossRefPubMedPubMedCentral
12.
Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331–42.CrossRefPubMed
13.
Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555–67.CrossRefPubMed
14.
Campbell R, Pound P, Pope C, Britten N, Pill R, Morgan M, Donovan J. Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. Soc Sci Med. 2003;56(4):671–84.CrossRefPubMed
15.
Gomersall T, Madill A, Summers LK. A metasynthesis of the self-management of type 2 diabetes. Qual Health Res. 2011;21(6):853–71.CrossRefPubMed
16.
Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011;93(1):1–9. https://​doi.​org/​10.​1016/​j.​diabres.​2011.​02.​002.CrossRefPubMed
17.
Gherman A, Schnur J, Montgomery G, Sassu R, Veresiu I, David D. How are adherent people more likely to think? A meta-analysis of health beliefs and diabetes self-care. Diabetes Educ. 2011;37(3):392–408.CrossRefPubMed
18.
Odegard PS, Capoccia K. Medication taking and diabetes. Diabetes Educ. 2007;33(6):1014–29.CrossRefPubMed
19.
Peeters B, Van Tongelen I, Boussery K, Mehuys E, Remon JP, Willems S. Factors associated with medication adherence to oral hypoglycaemic agents in different ethnic groups suffering from type 2 diabetes: a systematic literature review and suggestions for further research. Diabet Med. 2011;28(3):262–75.PubMed
20.
Majeed-Ariss R, Jackson C, Knapp P, Cheater FM. A systematic review of research into black and ethnic minority patients’ views on self-management of type 2 diabetes. Health Expect. 2015;18(5):625–42.CrossRefPubMed
21.
Wang HF, Yeh MC. Psychological resistance to insulin therapy in adults with type 2 diabetes: mixed-method systematic review. J Adv Nurs. 2012;68(4):743–57.CrossRefPubMed
22.
Polinski JM, Smith BF, Curtis BH, Seeger JD, Choudhry NK, Connolly JG, Shrank WH. Barriers to insulin progression among patients with type 2 diabetes: a systematic review. Diabetes Educ. 2013;39(1):53–65.CrossRefPubMed
23.
Purnell TS, Joy S, Little E, Bridges JF, Maruthur N. Patient preferences for noninsulin diabetes medications: a systematic review. Diabetes Care. 2014;37(7):2055–62. https://​doi.​org/​10.​2337/​dc13-2527.CrossRefPubMedPubMedCentral
24.
Brundisini F, Vanstone M, Hulan D, DeJean D, Giacomini M. Type 2 diabetes patients’ and providers’ differing perspectives on medication nonadherence: a qualitative meta-synthesis. BMC Health Serv Res. 2015;15(1):516.CrossRefPubMedPubMedCentral
25.
Garrofe BC, Bjornberg A, Phang AY. Euro diabetes index 2014 report. 2014. Available from: https://​old.​healthpowerhouse​.​com/​publications/​euro-diabetes-index-2014/​.
26.
Noblit GW, Hare RD, Hare RD. Meta-ethnography: synthesizing qualitative studies. Thousand Oaks: Sage; 1988.CrossRef
27.
Britten N, Campbell R, Pope C, Donovan J, Morgan M, Pill R. Using meta ethnography to synthesise qualitative research: a worked example. J Health Serv Res Policy. 2002;7(4):209–15.CrossRefPubMed
28.
Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, Campbell R. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.CrossRefPubMed
29.
CASP UK. CASP qualitative research checklist. 2010. Available at: http://​www.​casp-uk.​net/​checklists. Accessed 1 Apr 2014.
30.
Campbell R, Pound P, Morgan M, Daker-White G, Britten N, Pill R, Yardley L, Pope C, Donovan J. Evaluating meta ethnography: systematic analysis and synthesis of qualitative research. Health Technol Assess. 2012;15:43. https://​doi.​org/​10.​3310/​hta15430.CrossRef
31.
Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med. 2009;361(18):1736–47.CrossRefPubMed
32.
Lawton J, Ahmad N, Hallowell N, Hanna L, Douglas M. Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study. BMJ. 2005;330(7502):1247.CrossRefPubMedPubMedCentral
33.
Lawton J, Peel E, Parry O, Araoz G, Douglas M. Lay perceptions of type 2 diabetes in Scotland: bringing health services back in. Social Sci Med. 2005;60(7):1423–35.CrossRef
34.
Lawton J, Peel E, Parry O, Douglas M. Patients’ perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study. Diabet Med. 2008;25(4):491–5.CrossRefPubMed
35.
Parry O, Peel E, Douglas M, Lawton J. Issues of cause and control in patient accounts of Type 2 diabetes. Health Educ Res. 2005;21(1):97–107.CrossRefPubMed
36.
Morris JE, Povey RC, Street CG. Experiences of people with type 2 diabetes who have changed from oral medication to self-administered insulin injections. Pract Diabetes. 2005;22(7):239–43.CrossRef
37.
Phillips A. Experiences of patients with type 2 diabetes starting insulin therapy. Nurs Stand. 2007;21(23):35–41.CrossRefPubMed
38.
Khan H, Lasker SS, Chowdhury TA. Prevalence and reasons for insulin refusal in Bangladeshi patients with poorly controlled Type 2 diabetes in East London. Diabet Med. 2008;25(9):1108–11.CrossRefPubMed
39.
Noakes H. Perceptions of black African and African-Caribbean people regarding insulin. J Diabetes Nurs. 2010;14(4):148–56.
40.
Jenkins N, Hallowell N, Farmer AJ, Holman RR, Lawton J. Initiating insulin as part of the treating to target in type 2 diabetes (4-T) trial: an interview study of patients’ and health professionals’ experiences. Diabetes Care. 2010;33(10):2178–80.CrossRefPubMedPubMedCentral
41.
Jenkins N, Hallowell N, Farmer AJ, Holman RR, Lawton J. Participants’ experiences of intensifying insulin therapy during the treating to target in type 2 diabetes (4-T) trial: qualitative interview study. Diabet Med. 2011;28(5):543–8.CrossRefPubMed
42.
Brod M, Alolga SL, Meneghini L. Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities. Patient. 2014;7(4):437–50.CrossRefPubMedPubMedCentral
43.
Patel N, Stone MA, McDonough C, Davies MJ, Khunti K, Eborall H. Concerns and perceptions about necessity in relation to insulin therapy in an ethnically diverse UK population with type 2 diabetes: a qualitative study focusing mainly on people of South Asian origin. Diabet Med. 2015;32(5):635–44.CrossRefPubMed
44.
Bissell P, May CR, Noyce PR. From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc Sci Med. 2004;58(4):851–62.CrossRefPubMed
45.
Stone M, Pound E, Pancholi A, Farooqi A, Khunti K. Empowering patients with diabetes: a qualitative primary care study focusing on South Asians in Leicester, UK. Fam Pract. 2005;22(6):647–52.CrossRefPubMed
46.
Brown K, Avis M, Hubbard M. Health beliefs of African-Caribbean people with type 2 diabetes: a qualitative study. Br J Gen Pract. 2007;57(539):461–9.PubMedPubMedCentral
47.
Vermeire E, Hearnshaw H, Rätsep A, Levasseur G, Petek D, van Dam H, van der Horst F, Vinter-Repalust N, Wens J, Dale J, Van Royen P. Obstacles to adherence in living with type-2 diabetes: an international qualitative study using meta-ethnography (EUROBSTACLE). Primary Care Diabetes. 2007;1(1):25–33.CrossRefPubMed
48.
Hood G, Huber J, Gustaffson U, Scambler S, Asimakopoulou K. ‘With age comes wisdom almost always too late’: older adults’ experiences of T2DM. Eur Diabetes Nurs. 2009;6(1):23–8.CrossRef
49.
Stack RJ, Elliott RA, Noyce PR, Bundy C. A qualitative exploration of multiple medicines beliefs in co-morbid diabetes and cardiovascular disease. Diabet Med. 2008;25(10):1204–10.CrossRefPubMed
50.
Bower P, Harkness E, Macdonald W, Coventry P, Bundy C, Moss-Morris R. Illness representations in patients with multimorbid long-term conditions: qualitative study. Psychol Health. 2012;27(10):1211–26.CrossRefPubMed
51.
Gordon DR. Embodying illness, embodying cancer. Cult Med Psychiatry. 1990;14(2):275–97.PubMed
52.
Cohen MZ, Tripp-Reimer T, Smith C, Sorofman B, Lively S. Explanatory models of diabetes: patient practitioner variation. Soc Sci Med. 1994;38(1):59–66.CrossRefPubMed
53.
Frank AW. The rhetoric of self-change: illness experience as narrative. Sociol Q. 1993;34(1):39–52.CrossRef
54.
Polonsky WH, Jackson RA. What’s so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clin Diabetes. 2004;22(3):147–50.CrossRef
55.
Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q. 1988;15(2):175–83.CrossRefPubMed
56.
Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005;28(10):2543–5.CrossRefPubMed
57.
Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1–24.CrossRef
58.
Aikens JE, Nease DE, Nau DP, Klinkman MS, Schwenk TL. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Family Med. 2005;3(1):23–30.CrossRef
59.
Kleinman A, Eisenberg L, Good B. Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research. Ann Intern Med. 1978;88(2):251–8.CrossRefPubMed
60.
Bury M. Chronic illness as biographical disruption. Sociol Health Illn. 1982;4(2):167–82.CrossRefPubMed
61.
Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. In: Rachman S, editor. Contributions to medical psychology, vol. 2. New York: Pergamon Press; 1980. p. 7–30.
62.
Brown SA. Diabetes and grief. Diabetes Educ. 1985;11(2):53–7.CrossRefPubMed
63.
Ahlström G. Experiences of loss and chronic sorrow in persons with severe chronic illness. J Clin Nurs. 2007;16(3a):76–83.CrossRefPubMed
64.
Savoca MR, Miller CK, Quandt SA. Profiles of people with type 2 diabetes mellitus: the extremes of glycemic control. Soc Sci Med. 2004;58(12):2655–66.CrossRefPubMed
65.
Ockleford E, Shaw RL, Willars J, Dixon-Woods M. Education and self-management for people newly diagnosed with type 2 diabetes: a qualitative study of patients’ views. Chronic Illness. 2008;4(1):28–37.CrossRefPubMed
66.
Haslbeck JW, Schaeffer D. Routines in medication management: the perspective of people with chronic conditions. Chronic Illness. 2009;5(3):184–96. https://​doi.​org/​10.​1177/​1742395309339873​.CrossRefPubMed
67.
Nothwehr F, Stump T. Health-promoting behaviors among adults with type 2 diabetes: findings from the Health and Retirement Study. Prev Med. 2000;30(5):407–14.CrossRefPubMed
68.
Lau DC. Diabetes and weight management. Primary Care Diabetes. 2010;1(4):S24–30.CrossRef
69.
Ross SA, Dzida G, Vora J, Khunti K, Kaiser M, Ligthelm RJ. Impact of weight gain on outcomes in type 2 diabetes. Curr Med Res Opin. 2011;27(7):1431–8.CrossRefPubMed
70.
Davies MJ, Gagliardino JJ, Gray LJ, Khunti K, Mohan V, Hughes R. Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review. Diabet Med. 2013;30(5):512–24.CrossRefPubMed
71.
McSharry J, McGowan L, Farmer AJ, French DP. Perceptions and experiences of taking oral medications for the treatment of Type 2 diabetes mellitus: a systematic review and meta-synthesis of qualitative studies. Diabet Med. 2016;33(10):1330–8.CrossRefPubMed

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »